XML 65 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Sep. 30, 2015
Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (2,524,331) $ 28,384
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization expense 141,435 205,180
Deferred income tax 6,129 59,314
Stock-based compensation expense 152,733 975,658
Amortization of financing costs 46,745 62,283
Amortization of debt discount (47,875) 177,963
Change in fair value of warrant and conversion feature liability 116,866 (122,135)
Changes in assets and liabilities:    
Accounts receivable (214,131) (993,669)
Other receivables (80,776) (5,382,617)
Due from affiliates 16,345 42,378
Prepaid expenses and advances (131,091) (14,167)
Deferred financing costs 513,646 0
Other assets 6,570 (347)
Accounts payable and accrued liabilities 1,592,267 2,170,739
Medical liabilities 76,638 668,779
Net cash used in operating activities (328,830) (2,122,257)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition, net of cash and cash equivalents acquired 0 (1,947,431)
Property and equipment acquired (42,572) (15,583)
Net cash used in investing activities (42,572) (1,963,014)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of convertible note payable 0 2,000,000
Principal payments on term note payable (122,500) (726,082)
Contribution by non-controlling interest 0 550,000
Distributions to non-controlling interest (595,418) (600,000)
Debt issuance costs 0 (20,000)
Net cash (used in) provided by financing activities (717,918) 1,203,918
NET DECREASE IN CASH & CASH EQUIVALENTS (1,089,320) (2,881,353)
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD 5,014,242 6,831,478
CASH & CASH EQUIVALENTS, END OF PERIOD 3,924,922 3,950,125
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION:    
Interest paid 380,748 356,196
Income taxes paid 32,197 18,588
Non-Cash Financing Activities:    
Holdback liability 0 136,822
Convertible note warrant 0 487,620
Convertible note conversion feature 0 578,155
Acquisition related warrant consideration $ 0 $ 132,000